Advanced BioMedical Technologies Inc. (ABMT) Stock
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Advanced BioMedical Technologies Inc.
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
Advanced BioMedical Technologies Inc. (ABMT) stock trades at $0.00 with a market capitalization of $50000. The stock is valued at a price-to-earnings (P/E) ratio of -0.07, price-to-book of 0.00, price-to-sales of 0.32. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Advanced BioMedical Technologies Inc. generates a return on equity (ROE) of 12.50%, above the typical market average, return on capital employed of 2.27%, an operating margin of -66.38%, a net profit margin of 0.00%.
Official website: abtlafleur.com